Newman James W. Jr. - Net Worth and Insider Trading
Newman James W. Jr. Net Worth
The estimated net worth of Newman James W. Jr. is at least $12,790 dollars as of 2024-11-13. Newman James W. Jr. is the Director of Adial Pharmaceuticals Inc and owns about 12,539 shares of Adial Pharmaceuticals Inc (ADIL) stock worth over $12,790. Details can be seen in Newman James W. Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Newman James W. Jr. has not made any transactions after 2021-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Newman James W. Jr.
Newman James W. Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Newman James W. Jr. owns 1 companies in total, including Adial Pharmaceuticals Inc (ADIL) .
Click here to see the complete history of Newman James W. Jr.’s form 4 insider trades.
Insider Ownership Summary of Newman James W. Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals Inc | 2021-11-26 | director |
Newman James W. Jr. Latest Holdings Summary
Newman James W. Jr. currently owns a total of 1 stock. Newman James W. Jr. owns 12,539 shares of Adial Pharmaceuticals Inc (ADIL) as of November 26, 2021, with a value of $12,790.
Latest Holdings of Newman James W. Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADIL | Adial Pharmaceuticals Inc | 2021-11-26 | 12,539 | 1.02 | 12,790 |
Holding Weightings of Newman James W. Jr.
Newman James W. Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Newman James W. Jr. has made a total of 2 transactions in Adial Pharmaceuticals Inc (ADIL) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Adial Pharmaceuticals Inc is the acquisition of 400 shares on November 26, 2021, which cost Newman James W. Jr. around $28,500.
Insider Trading History of Newman James W. Jr.
- 1
Newman James W. Jr. Trading Performance
GuruFocus tracks the stock performance after each of Newman James W. Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Newman James W. Jr. is -13.15%. GuruFocus also compares Newman James W. Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Newman James W. Jr. within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Newman James W. Jr.'s insider trading performs compared to the benchmark.
Performance of Newman James W. Jr.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.13 | | | | | |
| Relative Return to S&P 500(%) | -6.93 | | | | | |
Newman James W. Jr. Ownership Network
Ownership Network List of Newman James W. Jr.
Ownership Network Relation of Newman James W. Jr.
Newman James W. Jr. Owned Company Details
What does Adial Pharmaceuticals Inc do?
Who are the key executives at Adial Pharmaceuticals Inc?
Newman James W. Jr. is the director of Adial Pharmaceuticals Inc. Other key executives at Adial Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Stilley William B. Iii , director & 10 percent owner Bankole A. Johnson , and COO and CFO Joseph Truluck .
Adial Pharmaceuticals Inc (ADIL) Insider Trades Summary
Over the past 18 months, Newman James W. Jr. made no insider transaction in Adial Pharmaceuticals Inc (ADIL). Other recent insider transactions involving Adial Pharmaceuticals Inc (ADIL) include a net purchase of 700 shares made by Kevin Schuyler ,
In summary, during the past 3 months, insiders sold 0 shares of Adial Pharmaceuticals Inc (ADIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adial Pharmaceuticals Inc (ADIL) were sold and 700 shares were bought by its insiders, resulting in a net purchase of 700 shares.
Adial Pharmaceuticals Inc (ADIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adial Pharmaceuticals Inc Insider Transactions
Newman James W. Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Newman James W. Jr.. You might contact Newman James W. Jr. via mailing address: 1180 Seminole Trail, Suite 495, Charlottesville Va 22901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
